Peytant combined self-expanding nitinol with human amnion-derived biomaterial for a device that's won FDA De Novo authorization.

Ralf Garczorz says he's convinced medtech has tremendous potential for improvement. But how can we unleash it?

Velosity said the EcoVadis rating reinforces its efforts to align with global sustainability standards and customer ...